KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Apr 12, 2016 $9.42 $10.18 $8.83 $9.43 24 544
Apr 11, 2016 $10.34 $10.80 $9.30 $9.33 16 426
Apr 08, 2016 $9.70 $10.68 $9.47 $10.16 12 516
Apr 07, 2016 $9.64 $10.15 $9.63 $9.87 14 587
Apr 06, 2016 $9.35 $9.98 $8.90 $9.52 19 029
Apr 05, 2016 $9.20 $9.35 $8.57 $9.30 9 316
Apr 04, 2016 $9.24 $9.98 $8.84 $9.29 39 934
Apr 01, 2016 $8.60 $9.30 $7.93 $8.95 18 429
Mar 31, 2016 $8.62 $9.15 $7.17 $8.60 52 764
Mar 30, 2016 $7.84 $8.59 $6.93 $8.12 34 115
Mar 29, 2016 $8.21 $8.75 $7.52 $7.85 20 400
Mar 28, 2016 $8.49 $8.79 $8.01 $8.15 7 700
Mar 24, 2016 $8.94 $9.54 $8.43 $8.50 30 800
Mar 23, 2016 $8.78 $9.12 $8.45 $9.06 22 900
Mar 22, 2016 $8.68 $9.31 $8.31 $8.86 27 000
Mar 21, 2016 $8.46 $9.00 $8.46 $8.70 16 300
Mar 18, 2016 $9.17 $10.00 $8.32 $8.54 233 500
Mar 17, 2016 $10.74 $10.78 $8.02 $8.97 34 900
Mar 16, 2016 $10.26 $10.99 $10.26 $10.75 120 200
Mar 15, 2016 $9.56 $12.09 $9.00 $10.20 69 200
Mar 14, 2016 $7.50 $9.75 $7.04 $9.65 37 800
Mar 11, 2016 $7.28 $7.41 $7.10 $7.14 16 300
Mar 10, 2016 $7.10 $7.15 $6.96 $6.97 7 800
Mar 09, 2016 $7.05 $7.47 $6.95 $7.02 11 400
Mar 08, 2016 $7.11 $7.36 $6.83 $6.98 14 700
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT